PCM Task Force Chair: Andreas Lundqvist
The immune system plays an important role in response to oncological therapy, and profiling of the immune system can help to identify biomarkers to guide treatment decisions and prognosis. If you are interested in how we can assist in immune profiling, please contact Andreas Lundqvist (andreas.lundqvist@ki.se).
Position paper by PCM Program steering group members Eskil Degsell and Mats Brommels on the need for a change in perspective in the collaboration between patient, relatives and Health care providers.
Datum: November 8, 2023
Plats: -
Information: Personalised/Precision Cancer Medicine – från Teknik till TerapiEfterutbildningskurs för specialister inom onkologi
Datum: September 20, 2023
Plats: -
Information: Nobel Symposium 175 Precision Medicine Transforms Healthcare: A New Trajectory for Research and Innovation
